I agree that this site is using cookies. You can find further informations here.
X
Kushlaf, Hani
60  results:
Search for persons X
?
1

P028: Switching treatment to cipaglucosidase alfa+miglustat..:

Kishnani, Priya ; Byrne, Barry ; Claeys, Kristl...
Genetics in Medicine Open.  2 (2024)  - p. 100905 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Minimal clinically important differences in six-minute walk..:

Claeys, Kristl G. ; Kushlaf, Hani ; Raza, Syed...
Orphanet Journal of Rare Diseases.  19 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Switching treatment to cipaglucosidase alfa plus miglustat ..:

Toscano, Antonio ; Byrne, Barry J. ; Claeys, Kristl G....
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 108059 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Efficacy of ravulizumab in patients with generalized myasth..:

Howard Jr, James F. ; Vu, Tuan ; Mantegazza, Renato...
Muscle & Nerve.  69 (2024)  5 - p. 556-565 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Minimal clinically important differences in six-minute walk..:

Schoser, Benedikt ; Kushlaf, Hani ; Hummel, Noemi...
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 108032 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Effect size analysis of cipaglucosidase alfa plus miglustat..:

Mozaffar, Tahseen ; Bratkovic, Drago ; Byrne, Barry J....
Molecular Genetics and Metabolism.  141 (2024)  2 - p. 107971 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Efficacy and safety of avalglucosidase alfa in participants..:

Kishnani, Priya S. ; Díaz-Manera, Jordi ; Kushlaf, Hani...
Molecular Genetics and Metabolism.  138 (2023)  2 - p. 107185 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Provisional practice recommendation for the management of m..:

Roy, Bhaskar ; Peck, Allison ; Evangelista, Teresinha...
Annals of Clinical and Translational Neurology.  10 (2023)  5 - p. 686-695 , 2023
Link: https://doi.org/10.1002/..
 
?
9

The applicability of the myasthenia gravis patient registry..:

Kushlaf, Hani
Muscle & Nerve.  66 (2022)  4 - p. 382-383 , 2022
Link: https://doi.org/10.1002/..
 
?
10

Development of a standard of care for patients with valosin..:

Korb, Manisha ; Peck, Allison ; Alfano, Lindsay N....
Orphanet Journal of Rare Diseases.  17 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
11

The avalglucosidase alfa phase 3 COMET trial in late-onset ..:

Kishnani, Priya ; Díaz-Manera, Jordi ; Kushlaf, Hani...
Molecular Genetics and Metabolism.  135 (2022)  2 - p. S66-S67 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Patient preference for virtual versus in‐person visits in n..:

Hafeez, Komal ; Kushlaf, Hani ; Al‐Sultani, Husam...
Muscle & Nerve.  66 (2022)  2 - p. 142-147 , 2022
Link: https://doi.org/10.1002/..
 
?
13

Safety and efficacy of avalglucosidase alfa versus alglucos..:

Diaz-Manera, Jordi ; Kishnani, Priya S ; Kushlaf, Hani...
The Lancet Neurology.  20 (2021)  12 - p. 1012-1026 , 2021
Link: https://doi.org/10.1016/..
 
?
14

A rare overlap of statin-induced anti-3-hydroxy-3-methyl-gl..:

Parikh, Priya ; Onuorah, Nneoma ; Kushlaf, Hani.
Rheumatology Advances in Practice.  5 (2021)  3 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
15

Patient Preference in Virtual Versus In-Person Visits in Ne..:

Komal, Fnu ; Al Sultani, Husam ; Habib, Ali...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
1-15